Cancer Database Query Results

Scientific Papers found: Click to Expand⟱

MF,

Ex,

The effects of pulsed electromagnetic field therapy on muscle strength and pain in patients with end-stage knee osteoarthritis: a randomized controlled trial

Trial,

Arthritis,

Sixty patients OA

*Strength↑, *Pain↓, *eff↑, *Dose↝,

6940-

MF,

Meta-analysis of the effectiveness and safety of magnetic stimulation for chronic pelvic pain

Review,

BPH,

*UFR↑, *other?, *Pain↓, *BloodF↑, *other↑, *Inflam↓, *QoL↑,

4425-

MF,

doxoR,

Brief Magnetic Field Exposure Stimulates Doxorubicin Uptake into Breast Cancer Cells in Association with TRPC1 Expression: A Precision Oncology Methodology to Enhance Chemotherapeutic Outcome

in-vitro,

BC,

4T1

in-vitro,

BC,

MCF7

ChemoSen↑, TRPC1↑, Dose↓, selectivity↑,

4356-

MF,

Pulsed electromagnetic fields synergize with graphene to enhance dental pulp stem cell-derived neurogenesis by selectively targeting TRPC1 channels

in-vitro,

Nor,

(10 min) and low amplitude (2 mT) PEMF

human dental pulp stem cells (hDPSCs)

*Diff↑, *TRPC1↑, *ROS↑,

4349-

MF,

Long-term effect of full-body pulsed electromagnetic field and exercise protocol in the treatment of men with osteopenia or osteoporosis: A randomized placebo-controlled trial

Trial,

ostP,

0.01–15,000 Hz, with sinusoidal, rectangular, multi-resonance, impulse, or sawtooth waveforms, the full-body maximum intensity is 30 gauss (3,000 microTesla)

Ninety-five males with osteopenia or osteoporosis

*BMD↑, *Pain↓, *QoL↑, *toxicity↓, *Dose↝, *Inflam↓,

4355-

MF,

Ambient and supplemental magnetic fields promote myogenesis via a TRPC1-mitochondrial axis: evidence of a magnetic mitohormetic mechanism

in-vitro,

Nor,

C2C12

 1.5 mT

C2C12 mouse skeletal myoblasts

*mt-OCR↑, *mt-ROS↑, *ECAR↑, *Dose↝, *Ca+2↑, *ATP↑, *other↑, *eff↓, *eff↝,

4354-

MF,

doxoR,

Modulated TRPC1 Expression Predicts Sensitivity of Breast Cancer to Doxorubicin and Magnetic Field Therapy: Segue Towards a Precision Medicine Approach

in-vivo,

BC,

MDA-MB-231

3mT, PEMFs stimulation for 1 h weekly for 5 weeks

NSG mice were purchased from The Jackson’s Laboratory and used at 8-10 weeks of age.

in-vivo,

BC,

MCF7

selectivity↑, Apoptosis↑, TumCI↓, tumCV↓, TumVol↓, eff↓, eff↑, ROS↑, Ca+2↑, TumCMig↓,

4348-

MF,

Pulsed electromagnetic field attenuates bone fragility in estrogen-deficient osteoporosis in rats

in-vivo,

ostP,

 (40 Hz and 25 Hzk), intensities (10 mT and 36.4 μT)

*BMD↑,

4353-

MF,

Chemo,

Pulsed Electromagnetic Field Enhances Doxorubicin-induced Reduction in the Viability of MCF-7 Breast Cancer Cells

in-vitro,

BC,

MCF7

 1 hours PEMF session (2.5 mT at 70 Hz) thrice a day for three consecutive days.

TumCCA↑, Apoptosis↑, eff↑, TumCCA↑, Casp↝, p‑CDK2↓, cycE/CCNE↓, Fas↑, BAX↑, survivin↓, Mcl-1↓, cl‑PARP↑, cl‑Casp7↑, cl‑Casp8↑, cl‑Casp9↑,

4352-

MF,

Differences in lethality between cancer cells and human lymphocytes caused by LF-electromagnetic fields

in-vitro,

lymphoma,

K562

B < or = 15 mT 50/60 Hz

NA,

U937

NA,

HL-60

Apoptosis↑, eff↑,

4351-

MF,

Inhibition of proliferation of human lymphoma cells U937 by a 50 Hz electromagnetic field

in-vitro,

lymphoma,

>3.5mT 50 Hz

Apoptosis↑,

4568-

MF,

Extremely low-frequency pulses of faint magnetic field induce mitophagy to rejuvenate mitochondria

Study,

NA,

*ETC↓, *OCR↑, *MMP↑, *ROS⇅, *MMP⇅,

4571-

MF,

Magnetic Fields and Reactive Oxygen Species

Review,

NA,

*ROS⇅, *ETC↓, Dose↝, Dose↝,

4099-

MF,

Extremely low frequency electromagnetic field reduces oxidative stress during the rehabilitation of post-acute stroke patients

Trial,

Stroke,

57 post-stroke patients

*ROS↓,

4102-

MF,

Modulation of antioxidant enzyme gene expression by extremely low frequency electromagnetic field in post-stroke patients

Human,

Stroke,

40 Hz frequency at 7 milliTesla, for 15 minutes per day, five days a week, over a four‑week

 Forty-eight post-stroke patients

*Catalase↑, *SOD1↑, *SOD2↑, *GPx1↑, *GPx4↑, *Dose↝,

4098-

MF,

Extremely low frequency electromagnetic field (ELF-EMF) reduces oxidative stress and improves functional and psychological status in ischemic stroke patients

Trial,

Stroke,

ELF-EMF field of 40 Hz, 7 mT for 15 min/day for 4 weeks (5 days a week)

post-stroke patients. Fifty-seven

*antiOx↑, *cognitive↑, *Dose↝,

4097-

MF,

Theta Frequency Electromagnetic Stimulation Enhances Functional Recovery After Stroke

Trial,

Stroke,

mice

*motorD↑, *eff↑, *Dose↝,

4096-

MF,

Extremely Low‐Frequency and Low‐Intensity Electromagnetic Field Technology (ELF‐EMF) Sculpts Microtubules

in-vitro,

AD,

*p‑tau↓, *neuroP↑, *Dose↝,

4095-

MF,

Frequency-tuned electromagnetic field therapy improves post-stroke motor function: A pilot randomized controlled trial

Trial,

Stroke,

*Dose↝, *motorD↑,

4148-

MF,

Increase in Blood Levels of Growth Factors Involved in the Neuroplasticity Process by Using an Extremely Low Frequency Electromagnetic Field in Post-stroke Patients

Human,

Stroke,

magnetic induction of 5 mT, 40 Hz, rectangular and bipolar waveforms) was conducted in the ELF-EMF group

*neuroP↑, *BDNF↑, *Dose↝,

4094-

MF,

EMAGINE-Study protocol of a randomized controlled trial for determining the efficacy of a frequency tuned electromagnetic field treatment in facilitating recovery within the subacute phase following ischemic stroke

Study,

Stroke,

*neuroP↑, *Dose↝,

4105-

MF,

Extremely low frequency electromagnetic fields stimulation modulates autoimmunity and immune responses: a possible immuno-modulatory therapeutic effect in neurodegenerative diseases

Review,

AD,

*Inflam↓, *neuroP↑, *NO↑, *ROS↓, *NO↓, *MCP1/CCL2↑, *HSP70/HSPA5↑, *antiOx↑, *NRF2↑, *NF-kB↓,

4147-

MF,

PEMFs Restore Mitochondrial and CREB/BDNF Signaling in Oxidatively Stressed PC12 Cells Targeting Neurodegeneration

in-vitro,

AD,

PC12

PC12 cells exposed to hydrogen peroxide (H2O2)

*ROS↓, *Catalase↑, *MMP↑, *Casp3↓, *p‑ERK↓, *cAMP↑, *p‑CREB↑, *BDNF↑, *neuroP↑,

4093-

MF,

Low-intensity electromagnetic fields induce human cryptochrome to modulate intracellular reactive oxygen species

in-vivo,

NA,

Drosophila fly

*ROS↑, *eff↑,

4146-

MF,

Pulsed electromagnetic field enhances brain-derived neurotrophic factor expression through L-type voltage-gated calcium channel- and Erk-dependent signaling pathways in neonatal rat dorsal root ganglion neurons

in-vivo,

AD,

50Hz and 1mT PEMF for 2h

rat

*BDNF↑, *ERK↑,

4092-

MF,

Mechanisms and therapeutic effectiveness of pulsed electromagnetic field therapy in oncology

Review,

Var,

Apoptosis↑, selectivity↑, ROS↑, Catalase↓, TumVol↓, angioG↓, Ca+2↝, eff↝, angioG↓, Imm↝, TNF-α↑, Casp8↑,

4116-

MF,

Low‑frequency pulsed electromagnetic field promotes functional recovery, reduces inflammation and oxidative stress, and enhances HSP70 expression following spinal cord injury

in-vivo,

NA,

spinal cord-injured rats.

*Inflam↓, *TNF-α↓, *IL1β↓, *iNOS↓, *ROS↓, *Catalase↑, *SOD↑, HSP70/HSPA5↑,

4106-

MF,

Cognitive Decline: Current Intervention Strategies and Integrative Therapeutic Approaches for Alzheimer's Disease

Review,

AD,

*cognitive↑, *memory↑, *Aβ↓, *neuroP↑,

4109-

MF,

Overexpression of miR-26b-5p regulates the cell cycle by targeting CCND2 in GC-2 cells under exposure to extremely low frequency electromagnetic fields

in-vitro,

NA,

50 Hz ELF-EMF for 72 h (5 min on/10 min off) at magnetic field intensities of 1 mT, 2 mT and 3 mT.

*other↝,

4110-

MF,

Pulsed Electromagnetic Fields: A Novel Attractive Therapeutic Opportunity for Neuroprotection After Acute Cerebral Ischemia

Review,

Stroke,

*ROS↓, *Inflam↓, *other↝, *neuroP↑, *Apoptosis↓, *Hif1a↝,

4111-

MF,

Coupling of pulsed electromagnetic fields (PEMF) therapy to molecular grounds of the cell

Review,

Arthritis,

*Inflam↓, *Cartilage↑, *Pain↓, *QoL↑, *Dose↝, *VEGF↑, *NO↑, *TGF-β↑, *MMP9↓, *PGE2↑, *GPx3↑, *SOD2↑, *Catalase↑, *GSR↑, *Ca+2↑,

4112-

MF,

Novel protective effects of pulsed electromagnetic field ischemia/reperfusion injury rats

in-vivo,

Stroke,

rats

*cardioP↑, *Bcl-2↑, *BAX↓, *ROS↓,

4104-

MF,

Effects of exposure to extremely low-frequency electromagnetic fields on spatial and passive avoidance learning and memory, anxiety-like behavior and oxidative stress in male rats

in-vivo,

NA,

1 μT, 100 μT, 500 μT, and 2000 μT). After 60 days exposure (2 h/day

rats

*memory↑, *ROS↑,

4150-

MF,

Enhanced effect of combining bone marrow mesenchymal stem cells (BMMSCs) and pulsed electromagnetic fields (PEMF) to promote recovery after spinal cord injury in mice

in-vitro,

NA,

*BDNF↑, *VEGF↑,

4149-

MF,

Pulsed Electro-Magnetic Field (PEMF) Effect on Bone Healing in Animal Models: A Review of Its Efficacy Related to Different Type of Damage

Review,

NA,

*other↑, *BDNF↑, *BMPs↑, *BMD↑,

4100-

MF,

Neurobiological effects and mechanisms of magnetic fields: a review from 2000 to 2023

Review,

Var,

*memory↑, *Mood⇅,

4117-

MF,

Pulsed electromagnetic fields improve the healing process of Achilles tendinopathy: a pilot study in a rat model

in-vivo,

NA,

1.5 mT and 75 Hz 8h/d

68 Sprague Dawley rats

*other↑,

4118-

MF,

Effects of transcranial magnetic stimulation on neurobiological changes in Alzheimer's disease

Review,

AD,

*cognitive↑, *BDNF↑, *neuroP↑, *memory↑, *ROS↓, *antiOx↑, *Aβ↓, *eff↑,

4119-

MF,

Therapeutic potential and mechanisms of repetitive transcranial magnetic stimulation in Alzheimer’s disease: a literature review

Review,

AD,

*cognitive↑, *memory↑, *motorD↑, *eff↑, *eff↑, *Dose↝, *Dose↝, *Dose↝, *BDNF↑, *Aβ↓, *eff↑,

4120-

MF,

Low-Frequency Repetitive Transcranial Magnetic Stimulation of the Right Dorsolateral Prefrontal Cortex Enhances Recognition Memory in Alzheimer's Disease

Human,

AD,

24 mild AD patients received sham and real 1Hz rTMS over the left and right dorsolateral prefrontal cortex

*memory↑,

4103-

MF,

Comparing the Effects of Long-term Exposure to Extremely Low-frequency Electromagnetic Fields With Different Values on Learning, Memory, Anxiety, and β-amyloid Deposition in Adult Rats

in-vivo,

NA,

 1, 100, 500, and 2000 microtesla (μT), 50 Hz frequency for one h/day for two months,

Rats

*Dose↝, *memory↑, *ROS↑, *MDA↑,

4101-

MF,

Benign Effect of Extremely Low-Frequency Electromagnetic Field on Brain Plasticity Assessed by Nitric Oxide Metabolism during Poststroke Rehabilitation

Human,

Stroke,

40 Hz, 7 mT, for 15 min/day

Forty-eight patients

*motorD↑, *cognitive↑, *eff↑, *NO↑, *other↝, *neuroP↑,

3457-

MF,

Cellular stress response to extremely low‐frequency electromagnetic fields (ELF‐EMF): An explanation for controversial effects of ELF‐EMF on apoptosis

Review,

Var,

Apoptosis↑, H2O2↑, ROS↑, eff↑, eff↑, Ca+2↑, MAPK↑, *Catalase↑, *SOD1↑, *GPx1↑, *GPx4↑, *NRF2↑, TumAuto↑, ER Stress↑, HSPs↑, SIRT3↑, ChemoSen↑, UPR↑, other↑, PI3K↓, JNK↑, p38↑, eff↓, *toxicity?,

3735-

MF,

Examining the effects of extremely low-frequency magnetic fields on cognitive functions and functional brain markers in aged mice

in-vivo,

AD,

50 Hz ELF-MF at 1 mT for 8 h/day, 5 days/week for 12 consecutive weeks

mice

*APP∅, *Aβ∅, *Inflam∅, *memory∅,

3746-

MF,

Low-Frequency Pulsed Electromagnetic Field Is Able to Modulate miRNAs in an Experimental Cell Model of Alzheimer's Disease

in-vitro,

AD,

3 mT; 75 Hz

*cognitive↑, *memory↑, *BACE/β-secretase↓,

3744-

MF,

Cognitive improvement via a modulated rhythmic pulsed magnetic field in D-galactose-induced accelerated aging mice

in-vivo,

AD,

mice

*cognitive↑, *memory↑,

3742-

MF,

The role of magnetic fields in neurodegenerative diseases

Review,

AD,

Review,

Park,

cognitive↑,

3741-

MF,

Promising application of Pulsed Electromagnetic Fields (PEMFs) in musculoskeletal disorders

Review,

NA,

usually less than 100 Hz and the magnetic flux density is between 0.1 m T and 30 m T.

*eff↑, *BMD↑, *Inflam↓, *PGE2↓, *IL6↓, *IL8↓, *NF-kB↓, *mTOR↝,

3740-

MF,

Gamma rhythm low field magnetic stimulation alleviates neuropathologic changes and rescues memory and cognitive impairments in a mouse model of Alzheimer's disease

in-vivo,

AD,

magnetic fields was changed every 4 minutes (between linear gradient and approximate distribution), and the rhythm was gradually increased every 8 minutes (30, 32.25, 34.5, 37, and 40 Hz)

mice

*cognitive↑, *Dose↝, *Aβ↓, *PSD95↑,

3739-

MF,

Early intervention using long-term rhythmic pulsed magnetic stimulation alleviates cognitive decline in a 5xFAD mouse model of Alzheimer's disease

in-vivo,

AD,

40 Hz, repeated at 5 Hz for 1 h/d for 8 consecutive weeks.

10-week-old AD mice treated with cPMF

*memory↑, *cognitive↑, *Aβ↓, *FGF↑,

Showing Research Papers: 5801 to 5850 of 8269
Prev Page 117 of 166 Next

* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 8269

Pathway results for Effect on Cancer / Diseased Cells:

Functional Outcomes(tgid=23) ⓘ

cognitive↑, 1, TumVol↓, 2,
Total Targets: 46

Pathway results for Effect on Normal Cells:

NA, unassigned(tgid=0) ⓘ

UFR↑, 1,

Redox & Oxidative Stress(tgid=1) ⓘ

antiOx↑, 3, Catalase↑, 5, GPx1↑, 2, GPx3↑, 1, GPx4↑, 2, GSR↑, 1, MDA↑, 1, NRF2↑, 2, ROS↓, 7, ROS↑, 4, ROS⇅, 2, mt-ROS↑, 1, SOD↑, 1, SOD1↑, 2, SOD2↑, 2,

Mitochondria & Bioenergetics(tgid=3) ⓘ

ATP↑, 1, ETC↓, 2, MMP↑, 2, MMP⇅, 1, OCR↑, 1, mt-OCR↑, 1,

Core Metabolism/Glycolysis(tgid=4) ⓘ

cAMP↑, 1, p‑CREB↑, 1, ECAR↑, 1,

Cell Death(tgid=5) ⓘ

Apoptosis↓, 1, BAX↓, 1, Bcl-2↑, 1, Casp3↓, 1, iNOS↓, 1,

Transcription & Epigenetics(tgid=7) ⓘ

other?, 1, other↑, 4, other↝, 3,

Protein Folding & ER Stress(tgid=8) ⓘ

HSP70/HSPA5↑, 1,

Proliferation, Differentiation & Cell State(tgid=12) ⓘ

Diff↑, 1, ERK↑, 1, p‑ERK↓, 1, FGF↑, 1, mTOR↝, 1,

Migration(tgid=13) ⓘ

APP∅, 1, Ca+2↑, 2, Cartilage↑, 1, MMP9↓, 1, TGF-β↑, 1, TRPC1↑, 1,

Angiogenesis & Vasculature(tgid=14) ⓘ

Hif1a↝, 1, NO↓, 1, NO↑, 3, VEGF↑, 2,

Immune & Inflammatory Signaling(tgid=16) ⓘ

IL1β↓, 1, IL6↓, 1, IL8↓, 1, Inflam↓, 7, Inflam∅, 1, MCP1/CCL2↑, 1, NF-kB↓, 2, PGE2↓, 1, PGE2↑, 1, TNF-α↓, 1,

Synaptic & Neurotransmission(tgid=18) ⓘ

BDNF↑, 7, PSD95↑, 1, p‑tau↓, 1,

Protein Aggregation(tgid=19) ⓘ

Aβ↓, 5, Aβ∅, 1, BACE/β-secretase↓, 1,

Drug Metabolism & Resistance(tgid=21) ⓘ

Dose↝, 16, eff↓, 1, eff↑, 9, eff↝, 1,

Clinical Biomarkers(tgid=22) ⓘ

BloodF↑, 1, BMD↑, 4, BMPs↑, 1, IL6↓, 1,

Functional Outcomes(tgid=23) ⓘ

cardioP↑, 1, cognitive↑, 9, memory↑, 10, memory∅, 1, Mood⇅, 1, motorD↑, 4, neuroP↑, 9, Pain↓, 4, QoL↑, 3, Strength↑, 1, toxicity?, 1, toxicity↓, 1,
Total Targets: 85

Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include : 
  -low or high Dose
  -format for product, such as nano of lipid formations
  -different cell line effects
  -synergies with other products 
  -if effect was for normal or cancerous cells

Filter Conditions: Pro/AntiFlg:%  IllCat:%  CanType:%  Cells:%  prod#:%  Target#:%  State#:%  Dir#:%
  wNotes=0  sortOrder:rid,rpid

Cancer Database Query Results

Pathway results for Effect on Cancer / Diseased Cells:

Redox & Oxidative Stress(tgid=1) ⓘ

Cell Death(tgid=5) ⓘ

Transcription & Epigenetics(tgid=7) ⓘ

Protein Folding & ER Stress(tgid=8) ⓘ

Autophagy & Lysosomes(tgid=9) ⓘ

DNA Damage & Repair(tgid=10) ⓘ

Cell Cycle & Senescence(tgid=11) ⓘ

Proliferation, Differentiation & Cell State(tgid=12) ⓘ

Migration(tgid=13) ⓘ

Angiogenesis & Vasculature(tgid=14) ⓘ

Immune & Inflammatory Signaling(tgid=16) ⓘ

Drug Metabolism & Resistance(tgid=21) ⓘ

Functional Outcomes(tgid=23) ⓘ

Pathway results for Effect on Normal Cells:

NA, unassigned(tgid=0) ⓘ

Redox & Oxidative Stress(tgid=1) ⓘ

Mitochondria & Bioenergetics(tgid=3) ⓘ

Core Metabolism/Glycolysis(tgid=4) ⓘ

Cell Death(tgid=5) ⓘ

Transcription & Epigenetics(tgid=7) ⓘ

Protein Folding & ER Stress(tgid=8) ⓘ

Proliferation, Differentiation & Cell State(tgid=12) ⓘ

Migration(tgid=13) ⓘ

Angiogenesis & Vasculature(tgid=14) ⓘ

Immune & Inflammatory Signaling(tgid=16) ⓘ

Synaptic & Neurotransmission(tgid=18) ⓘ

Protein Aggregation(tgid=19) ⓘ

Drug Metabolism & Resistance(tgid=21) ⓘ

Clinical Biomarkers(tgid=22) ⓘ

Functional Outcomes(tgid=23) ⓘ

Home Page